EP0248548A3
Controlled release pharmaceutical composition
Abstract
A solid, controlled release, pharmaceutical composition comprising an active ingredient incorporated in a controlled release matrix comprising a water soluble polydextrose. The controlled release matrix may also contain at least one of a digestible C₈-C₅₀ substituted or unsubstituted hydrocarbon, especially a C₁₂-C₃₆ fatty alcohol, and a polyalkylene glycol, especially polyethylene glycol. Optionally, the matrix may contain a cellulose ether, especially a hydroxyalkylcellulose or a carboxyalkylcellulose.

Term
Term ended
Projected expiry passed 12 May 2007, 19.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both waysCites: the store holds 4 of 5
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0172984A1 | Cites | European Patent Office (EPO) | A | Search report |
| US3766165A | Cites | United States of America | A | Search report |
| US4459280A | Cites | United States of America | A | Search report |
| US4698264A | Cites | United States of America | XP | Search report |
| CHEMICAL ABSTRACTS, vol. 97, no. 15, October 11, 1982, Columbus, Ohio, (USA) R.P. ALLINGHAM: "Polydextrose-a new food ingredient; technical aspects", page 572, abstract-no. 125852p; & CHEM. FOODS BEVERAGES: Recent Dev. 1982, 293-303 | Non-patent | – | – | Search report |
28 members in 15 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 8613689 | United Kingdom | A | |
| 8613689 | United Kingdom | – | |
| 8613689 | – | – | – |
| GB19860013689 | – | – | – |
Members28
| Document | Office | Kind | |
|---|---|---|---|
| GB8613689D0 | United Kingdom | D0 | |
| FI872481A0 | Finland | A0 | |
| DK289387D0 | Denmark | D0 | |
| ZA873735B | South Africa | B | |
| IE871480L | Ireland | L | |
| DK289387A | Denmark | A | |
| FI872481A | Finland | A | |
| FI872481L | Finland | L | |
| EP0248548A2 | European Patent Office (EPO) | A2 | |
| AU7378787A | Australia | A | |
| JPS62292732A | Japan | A | |
| KR880000089A | Republic of Korea | A | |
| EP0248548A3This record | European Patent Office (EPO) | A3 | |
| US4828836A | United States of America | A | |
| KR890004688B1 | Republic of Korea | B1 | |
| AU602337B2 | Australia | B2 | |
| CA1297017C | Canada | C | |
| EP0248548B1 | European Patent Office (EPO) | B1 | |
| AT77943T | Austria | T | |
| ATE77943T1 | Austria | T1 | |
| DE3780222D1 | Germany | D1 | |
| DE3780222T2 | Germany | T2 | |
| GR3005191T3 | Greece | T3 | |
| ES2042561T3 | Spain | T3 | |
| FI92014B | Finland | B | |
| IE60757B1 | Ireland | B1 | |
| FI92014C | Finland | C | |
| JPH0780787B2 | Japan | B2 |
54 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Nl: lapsed or anulled due to non-payment of the annual feeLapsedNLV4 | NLV4 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Lu: last paid annual feeEPTA | EPTA | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Validation in greece3005191FG4A | FG4A | GR | |
| Fr: translation filedET | ET | EP | |
| Corresponds to:REF | REF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Designated contracting statesAK | AK | EP | |
| Corresponds to:REF | REF | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| It: last paid annual feeITTA | ITTA | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0248548
- Publication, DOCDB
- 0248548
- Publication, EPODOC
- EP0248548
- Application
- 87304188
- Application, DOCDB
- 87304188
- Application, EPODOC
- EP19870304188
Titles3
- English
- Controlled release pharmaceutical composition
- French
- Composition pharmaceutique à libération contrôlée
- German
- Pharmazeutische Zusammensetzung mit kontrollierter Wirkstofffreisetzung
Classification
- CPC, 3
- A61K9/205
- A61K9/2013
- A61K9/2031
- IPC, 10
- A61K47 36
- A61K9 20
- A61K9 22
- A61K9 26
- A61K9 50
- A61K9 52
- A61K31 165
- A61K31 19
- A61K31 52
- A61K47 00
Designated states1
- Contracting states, 1
- Sweden